A prospective, randomized, controlled, interventional clinical trial to evaluate the safety and efficacy of the medical monopoint reperfusion system for aspiration thrombectomy in acute ischemic stroke patients (SUMMIT MAX): Trial rationale and design.
Guilherme DabusAjit S PuriBen McGuinnessRyan A PriestAnsaar T RaiBradley A GrossOsama O ZaidatRicardo A HanelM Shazam HussainHamza A ShaikhJoey D EnglishThanh N NguyenPublished in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2024)
SUMMIT MAX is a randomized controlled trial comparing the effectiveness and safety of a new large bore class of aspiration devices to the currently largest FDA-cleared aspiration device available.
Keyphrases
- clinical trial
- ultrasound guided
- phase ii
- acute ischemic stroke
- study protocol
- phase iii
- cerebral ischemia
- liver failure
- healthcare
- acute myocardial infarction
- open label
- respiratory failure
- ischemia reperfusion injury
- double blind
- drug induced
- randomized controlled trial
- intensive care unit
- brain injury
- subarachnoid hemorrhage
- oxidative stress
- hepatitis b virus
- atrial fibrillation